Prevention of Female Cancers by Optimization of Selenium Levels in the Organism.

Clinical trial NCT04014283 · UNKNOWN

Trial details

NCT number: NCT04014283
Sponsor: Read-Gene S.A.
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Breast Neoplasms

Start date: 2014-10-01
Primary completion: 2023-11-01
Enrollment: 7000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.